Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Clin Breast Cancer. 2012 Apr;12(2):110–118. doi: 10.1016/j.clbc.2012.01.009

Figure 3.

Figure 3

A hormonally positive, HER2 negative cancer with low Ki67 in the right breast. The first image is baseline MRI prior to NAC. The second and the third images are follow-up MRI during NAC treatment. The fourth image is the last MRI after the completeness of NAC treatment. MRI indicates a 2.5cm residual tumor after NAC, which differs markedly from a 5.5 cm tumor found in surgical pathology.